6. Parkinson disease Clinical trials / Disease details


Clinical trials : 2,298 Drugs : 2,202 - (DrugBank : 350) / Drug target genes : 188 - Drug target pathways : 202

  
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT00004576
(ClinicalTrials.gov)
February 200017/2/2000Study of LY300164 for the Treatment of Parkinson's DiseaseAMPA Receptor Blockade With LY300164 in the Treatment of Parkinson's DiseaseDyskinesias;Parkinson DiseaseDrug: LY300164National Institute of Neurological Disorders and Stroke (NINDS)NULLCompletedN/AN/ABoth20Phase 2United States